Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amlodipine/valsartan - Novartis

X
Drug Profile

Amlodipine/valsartan - Novartis

Alternative Names: Amlodipine 10mg/Valsartan 160mg; Amlodipine besilate/valsartan; Amlodipine besylate/valsartan; Dafiro; Exforge; EXPO-G-Tab; ID1803; VAA489; Valsartan/amlodipine

Latest Information Update: 06 Dec 2019

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novartis
  • Class Antihypertensives; Branched-chain amino acids; Dihydropyridines; Ischaemic heart disorder therapies; Tetrazoles
  • Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypertension

Most Recent Events

  • 04 Dec 2019 IlDong Pharmaceutical plans a phase I pharmacodynamics/pharmacokinetic interaction and safety study in Healthy volunteers (ID-VARE-101; NCT04185090)
  • 28 Aug 2019 No recent reports of development identified for phase-I development in Hypertension(In volunteers) in South Korea (PO, Tablet)
  • 22 May 2019 Kyung Dong Pharmaceutical completes the phase I KD5001 trial in Hypertension (In volunteers) in South Korea (PO) (KCT0001660)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top